The Latest: Israeli study confirms vaccine efficacy (Good News)

The Latest: Israeli study confirms vaccine efficacy

People wearing face masks to protect against the spread of the coronavirus wait for signals to turn to green at a crossing in Tokyo, Monday, Feb. 15, 2021. Tokyo is under state of emergency as the government seeks to stop a surge of new coronavirus infections. (AP Photo/Koji Sasahara)

A large-scale Israeli study has pointed to the efficacy of the Pfizer/BioNTech vaccine at preventing symptomatic infections with the coronavirus

The Latest: Israeli study confirms vaccine efficacyBy The Associated PressThe Associated Press

JERUSALEM— A large-scale Israeli study has pointed to the efficacy of the Pfizer/BioNTech vaccine at preventing symptomatic infections with the coronavirus.

Clalit, the largest of Israel’s four health care providers, released a study Sunday that compared infections in 600,000 Israelis who had received the vaccine compared to 600,000 who were not immunized.

The study found a 94% drop in symptomatic infections and a 92% drop in serious cases of the disease among those vaccinated. It said “the efficacy of the vaccine is preserved in every age group,” particularly a week after the second dose of the vaccine.

The researchers said the preliminary findings of the ongoing research “is aimed at emphasizing to the population that has yet to vaccinate that the vaccine is highly effective and prevents serious illness.”

Israel launched its COVID-19 vaccine campaign in December. Since then, over a quarter of the population — 2.5 million people — have received two doses of the Pfizer/BioNTech vaccine, and over 42% have received the first shot, according to the Health Ministry.

Sharing is caring!

Leave a Reply

Your email address will not be published. Required fields are marked *